Literature DB >> 11165819

Evaluation of dissolution profiles using principal component analysis.

E Adams1, R De Maesschalck, B De Spiegeleer, Y Vander Heyden, J Smeyers-Verbeke, D L Massart.   

Abstract

The performance of principal component analysis (PCA) for the evaluation of dissolution profiles is examined and compared with other methods such as the similarity factor and the calculation of the area under the curve. Both simulated and real data from the pharmaceutical industry are used. The PCA scores plots of the dissolution curves provide information about the between- and within-batch variations. Differences in level or shape can be observed in the first two principal components (PCs). Irrelevant irregularities, which have a strong influence on the similarity factor, are neglected in PC1/PC2. To detect outliers in a set of dissolution curves, PCA was preferred above Hotelling's T2 test. In general, PCA is found to be a useful technique to examine dissolution data visually, but however, it does not contain criteria to decide if batches are similar or not. This can be done by combining PCA with the resampling with replacement or bootstrap method to construct confidence limits.

Entities:  

Mesh:

Year:  2001        PMID: 11165819     DOI: 10.1016/s0378-5173(00)00581-0

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Liqui-Tablet: the Innovative Oral Dosage Form Using the Newly Developed Liqui-Mass Technology.

Authors:  Matthew Lam; Kofi Asare-Addo; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2021-03-01       Impact factor: 3.246

2.  Liqui-Pellet: the Emerging Next-Generation Oral Dosage Form Which Stems from Liquisolid Concept in Combination with Pelletization Technology.

Authors:  Matthew Lam; Taravat Ghafourian; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2019-06-24       Impact factor: 3.246

3.  Optimising the release rate of naproxen liqui-pellet: a new technology for emerging novel oral dosage form.

Authors:  Matthew Lam; Taravat Ghafourian; Ali Nokhodchi
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

4.  Principal Component Analysis Applications in COVID-19 Genome Sequence Studies.

Authors:  Bo Wang; Lin Jiang
Journal:  Cognit Comput       Date:  2021-01-13       Impact factor: 4.890

5.  Development and validation of new discriminative dissolution method for carvedilol tablets.

Authors:  V Raju; K V R Murthy
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.